The cystatin-related epididymal spermatogenic protein inhibits the serine protease prohormone convertase 2.
The cystatin-related epididymal spermatogenic (CRES) protein is related to the family 2 cystatins of the cystatin superfamily of cysteine protease inhibitors. However, CRES lacks sequences important for cysteine protease inhibitory activity and is specifically expressed in reproductive and neuroendocrine tissues. Thus, CRES is distinct from cystatins and may perform unique tissue-specific functions. The purpose of the present study was to determine whether CRES functions as a protease inhibitor in in vitro assays. In contrast to mouse recombinant cystatin C, recombinant CRES did not inhibit the cysteine proteases papain and cathepsin B, suggesting that it probably does not function as a typical cystatin. CRES, however, inhibited the serine protease prohormone convertase 2 (PC2), a protease involved in prohormone processing in the neuroendocrine system, whereas cystatin C showed no inhibition. CRES did not inhibit subtilisin, trypsin, or the convertase family members, PC1 and furin, indicating that it selectively inhibits PC2. Kinetic analysis showed that CRES is a competitive inhibitor of PC2 with a K(i) of 25 nM. The removal of N-terminal sequences from CRES decreased its affinity for PC2, suggesting that the N terminus may be important for CRES to function as an inhibitor. These studies suggest that CRES is a cross-class inhibitor that may regulate proprotein processing within the reproductive and neuroendocrine systems.
Cornwall
Gail A
GA
Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, Texas 79430, USA. gail.cornwall@ttuhsc.edu
Cameron
Angus
A
Lindberg
Iris
I
Hardy
Daniel M
DM
Cormier
Nathaly
N
Hsia
Nelson
N
D000818:Animals; D001667:Binding, Competitive; D002401:Cathepsin B / Q000037:antagonists & inhibitors; D002460:Cell Line; D055316:Cystatin C; D015891:Cystatins / Q000737:chemistry / Q000235:genetics / Q000494:pharmacology*; D004822:Epididymis / Q000737:chemistry; D005260:Female; D007700:Kinetics; D008297:Male; D051379:Mice; D010053:Ovary / Q000737:chemistry; D010206:Papain / Q000037:antagonists & inhibitors; D010446:Peptide Fragments / Q000494:pharmacology; D010903:Pituitary Gland, Anterior / Q000737:chemistry; D045706:Proprotein Convertase 2; D012333:RNA, Messenger / Q000032:analysis; D011993:Recombinant Fusion Proteins / Q000494:pharmacology; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015842:Serine Proteinase Inhibitors / Q000494:pharmacology*; D013329:Structure-Activity Relationship; D013381:Subtilisins / Q000037:antagonists & inhibitors* / Q000235:genetics; D013737:Testis / Q000737:chemistry
C525031:Cst3 protein, mouse; D055316:Cystatin C; D015891:Cystatins; D010446:Peptide Fragments; D012333:RNA, Messenger; D011993:Recombinant Fusion Proteins; D015842:Serine Proteinase Inhibitors; C078310:Cst8 protein, mouse; D013381:Subtilisins; D045706:Proprotein Convertase 2; D002401:Cathepsin B; D010206:Papain